Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma
A phase 3 trial of Ziv-aflibercept in Uveal melanoma, run by Centre Hospitalier Universitaire de Nice, completed.
Overview
Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma is a phase 3 interventional study registered as NCT03172299 by Centre Hospitalier Universitaire de Nice, with 57 participants recorded, started 2017-06-08 and reaching its primary completion in 2025-01-31. Interventions recorded: Aflibercept Injection, False injection. Conditions recorded: Ocular Melanoma.
Linked to the drug Ziv-aflibercept because the registry names it among its interventions and Uveal melanoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialEvaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Shares Uveal melanoma and the tag pipeline.
- TrialA Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
Shares Ziv-aflibercept and the tag pipeline.
- TrialZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
Shares Ziv-aflibercept and the tag pipeline.
- TrialPHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases
Shares Uveal melanoma and the tag pipeline.
- TrialA Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Shares Uveal melanoma and the tag pipeline.
- TrialA Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Shares Uveal melanoma and the tag pipeline.
- TrialA Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Shares Uveal melanoma and the tag pipeline.
- TrialA Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma
Shares Uveal melanoma and the tag pipeline.